Harvard Bioscience, Inc. (HBIO) Reaches $3.12 After 6.00% Up Move; Fossil Group (FOSL)’s Sentiment Is 1.62

August 10, 2017 - By Richard Conner

The stock of Harvard Bioscience, Inc. (NASDAQ:HBIO) is a huge mover today! About 58,540 shares traded. Harvard Bioscience, Inc. (NASDAQ:HBIO) has declined 25.93% since August 10, 2016 and is downtrending. It has underperformed by 42.63% the S&P500.The move comes after 9 months positive chart setup for the $108.86M company. It was reported on Aug, 10 by Barchart.com. We have $3.31 PT which if reached, will make NASDAQ:HBIO worth $6.53 million more.

Fossil Group, Inc. is a design, marketing and distribution firm that specializes in consumer fashion accessories. The company has market cap of $425.52 million. The Company’s divisions include Americas, Europe and Asia. It currently has negative earnings. Each segment includes sales to wholesale and distributor customers, and sales through the Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Ratings analysis reveals 17% of Fossil’s analysts are positive. Out of 6 Wall Street analysts rating Fossil, 1 give it “Buy”, 2 “Sell” rating, while 3 recommend “Hold”. The lowest target is $23.0 while the high is $27.0. The stock’s average target of $25 is 184.74% above today’s ($8.78) share price. FOSL was included in 6 notes of analysts from October 27, 2016. The company was upgraded on Wednesday, November 16 by KeyBanc Capital Markets. The company was initiated on Thursday, October 27 by Buckingham Research. Mizuho maintained the shares of FOSL in report on Friday, November 4 with “Neutral” rating. Piper Jaffray upgraded the shares of FOSL in report on Monday, November 21 to “Neutral” rating. Telsey Advisory maintained Fossil Group Inc (NASDAQ:FOSL) on Friday, November 4 with “Market Perform” rating. Wells Fargo downgraded Fossil Group Inc (NASDAQ:FOSL) on Wednesday, February 15 to “Underperform” rating.

Since January 1, 0001, it had 0 buys, and 3 selling transactions for $23.79 million activity.

Pacifica Capital Investments Llc holds 4.64% of its portfolio in Fossil Group Inc for 360,750 shares. Underhill Investment Management Llc owns 305,650 shares or 4.58% of their US portfolio. Moreover, Clearline Capital Lp has 2.95% invested in the company for 251,085 shares. The Alabama-based Vulcan Value Partners Llc has invested 2.62% in the stock. Irving Magee Investment Management, a Pennsylvania-based fund reported 198,528 shares.

About 4.00M shares traded or 41.34% up from the average. Fossil Group Inc (FOSL) has declined 54.09% since August 10, 2016 and is downtrending. It has underperformed by 70.79% the S&P500.

Investors sentiment increased to 1.74 in Q4 2016. Its up 0.80, from 0.94 in 2016Q3. It improved, as 6 investors sold Harvard Bioscience, Inc. shares while 13 reduced holdings. 8 funds opened positions while 25 raised stakes. 20.98 million shares or 5.59% less from 22.23 million shares in 2016Q3 were reported. Jacobs Levy Equity Mngmt, New Jersey-based fund reported 54,308 shares. First Manhattan has invested 0% in Harvard Bioscience, Inc. (NASDAQ:HBIO). Spark Inv Mngmt Limited Liability Corp owns 103,700 shares. Deutsche Bancorporation Ag invested 0% of its portfolio in Harvard Bioscience, Inc. (NASDAQ:HBIO). Sei Invests Communications holds 0% or 288 shares. Walleye Trading Ltd Liability Com reported 0% in Harvard Bioscience, Inc. (NASDAQ:HBIO). Blackrock Inv Mgmt Limited has invested 0% in Harvard Bioscience, Inc. (NASDAQ:HBIO). 183,300 were reported by Axa. The Wisconsin-based Heartland Advisors has invested 0.34% in Harvard Bioscience, Inc. (NASDAQ:HBIO). Acadian Asset Mgmt Ltd Llc has 761,735 shares. Meristem Llp accumulated 12,368 shares. Segall Bryant And Hamill Ltd has 0.03% invested in Harvard Bioscience, Inc. (NASDAQ:HBIO) for 369,494 shares. Royal Savings Bank Of Canada reported 61 shares or 0% of all its holdings. Moreover, Jpmorgan Chase And has 0% invested in Harvard Bioscience, Inc. (NASDAQ:HBIO) for 6,117 shares. Clarivest Asset Mgmt Limited Com owns 209,176 shares or 0.02% of their US portfolio.

Since May 23, 2017, it had 4 buys, and 0 insider sales for $74,561 activity. LEWIS EARL R bought 10,000 shares worth $23,800. Green James W had bought 7,712 shares worth $19,666. 1,000 shares were bought by Gagnon Robert E., worth $2,330.